Alnylam Pharmaceuticals, Inc.
$38.08B- Market cap
- $35.61B
- Debt
- +$4.12B
- Cash
- −$1.66B
Capital structure 90% equity / 10% debt · EV / Revenue 10.25x · EV / EBITDA 63.82x
Quick read
Fair value engine
Each company valued on the other's multiple, then compared with the market price.
ALNY · current priceP/E 114.23x
$266.15Latest market snapshot
Implied fair value · at WYNN's multiple
$67.9474.5% below market
2.33 ALNY EPS (TTM)×29.16x WYNN P/E=$67.94
Market $266.15Implied $67.94
WYNN · current priceP/E 29.16x
$91.56Latest market snapshot
Implied fair value · at ALNY's multiple
$358.67291.7% above market
3.14 WYNN EPS (TTM)×114.23x ALNY P/E=$358.67
Market $91.56Implied $358.67